Quality of life in brain metastases radiation trials: a literature review - Wikidata - wikimedia - TriplyDB

Quality of life in brain metastases radiation trials: a literature review

Quality of life in brain metastases radiation trials: a literature review

http://www.wikidata.org/entity/Q36971728

about

Trastuzumab uptake and its relation to efficacy in an animal model of HER2-positive breast cancer brain metastasis The Brain Symptom and Impact Questionnaire in brain metastases patients: a prospective long-term follow-up study Prospective evaluation of quality of life effects in patients undergoing palliative radiotherapy for brain metastases Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 9 Radiotherapeutic Options for Symptom Control in Breast Cancer Palliative whole-brain radiotherapy and health- related quality of life for patients with brain metastasis in cancer Synergistic effect of therapeutic stem cells expressing cytosine deaminase and interferon-beta via apoptotic pathway in the metastatic mouse model of breast cancer.Quality of life and radiotherapy in brain metastasis patients.Veliparib in combination with whole-brain radiation therapy for patients with brain metastases from non-small cell lung cancer: results of a randomized, global, placebo-controlled study.Health Care Professionals' Evaluation of Quality of Life Issues in Patients With Brain Metastases.Validation of the Brain Symptom and Impact Questionnaire (BASIQ) to assess symptom and quality of life in brain metastases.Prognostic value of pre- and post-treatment health-related quality of life in predicting survival of patients with brain metastases.Changing Paradigms in the Rehabilitation of Inpatients with Brain Tumors.

P2860

Q33867316-F2373893-0873-4B1C-8EBA-07143AFBA0BF Q33913472-40325C75-FF39-4D6D-907F-48D364F2F761 Q34332364-8492CD8F-B6E4-43FB-A808-B223FF16ECC9 Q34854124-A89153FD-B62A-4683-A81C-ECDBD42FB66B Q34870231-3A1F36F7-3F88-46A6-98D6-8648C75EA49B Q36003567-0E5A10A8-31D0-43A8-828E-9DAFE5E31E78 Q36905824-4610F6F8-E166-4F70-B0A9-9AC03283B05A Q37454266-EA7D2A71-C83B-4ACA-A584-BB80574334EA Q37601465-5403BB53-0EA6-4D9F-8FFD-C59DB51DD543 Q47116701-54D0F43B-E838-4E8C-ABA8-DCE1B95D56E1 Q48063744-05971479-8E0E-45FD-94C6-1507570E023D Q52098047-0F9D098A-D610-4E70-957D-7FEF596063EF Q55456905-CBAD8212-BE56-437D-AABA-6FBC800850BF

P2860

Quality of life in brain metastases radiation trials: a literature review

http://www.wikidata.org/entity/Q36971728

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Quality of life in brain metastases radiation trials: a literature review

@en

type

label

Quality of life in brain metastases radiation trials: a literature review

@en

prefLabel

Quality of life in brain metastases radiation trials: a literature review

@en

P1433

Q36971728-225A9A28-0E21-425C-894E-D709B6761490

P1476

Q36971728-899E589A-6FF4-4BE9-A0BD-EC4EBE3D2085

P2093

Q36971728-869BD552-63E2-427E-B650-E28AC29D797C

Q36971728-917D3ABC-3389-442C-A522-5A55BD304AE1

Q36971728-A0500095-46D7-4CD4-8411-AE6F22982344

Q36971728-F22499A1-B69D-4A4D-8374-4E7122402C38

Q36971728-F7B6BAA8-67F3-44EB-AE4D-AB3099F496F8

P2860

Q36971728-0B81DCCF-1143-474D-AA05-240C921E4FF4

Q36971728-0D6D2AFD-CF7C-4C03-AA73-103E4B74A4A6

Q36971728-10AE96FE-0A2F-4EA1-86F7-8EA4371B35F2

Q36971728-12DBDA70-D355-4043-9B55-ABEDCEFB9A73

Q36971728-1E8EB474-AEA6-4F39-B82F-C8815104F063

Q36971728-1F0DB77F-2B24-4B96-8233-9A9AF5327EAE

Q36971728-25658AE5-AF7B-4DE0-AA03-3645552C328C

Q36971728-2808C5BF-46AF-4DEF-B8C9-60565E959A81

Q36971728-28593360-5E6F-4C61-8980-B042A4FB3E58

Q36971728-2B418189-1B22-4D82-8ACC-D88A67A462D3

P304

Q36971728-4454E309-BF83-4569-A2EB-A97027C3BAE4

P31

Q36971728-B856ED44-4F56-4EB4-9D20-B00E96BEF5CA

P356

Q36971728-5B0DF501-49D8-4F27-8D83-8506C0A41ED6

P433

Q36971728-0B893CA8-BFF5-4226-9BF1-BEFF880751C5

P478

Q36971728-79AC3835-4F87-4C1E-B7AA-4A3691851FF0

P577

Q36971728-3549BE50-0F49-4931-9091-883E784828EE

P698

Q36971728-0596DF33-8606-4878-B913-5E1411B65723

P932

Q36971728-DBC8902B-9E8F-4C61-9049-61350C899A94

P356

P1433

Current Oncology

P1476

Quality of life in brain metastases radiation trials: a literature review

@en

P2093

A Hird

http://www.w3.org/2001/XMLSchema#string

A Kirou-Mauro

http://www.w3.org/2001/XMLSchema#string

E Chow

http://www.w3.org/2001/XMLSchema#string

J Napolskikh

http://www.w3.org/2001/XMLSchema#string

J Wong

http://www.w3.org/2001/XMLSchema#string

P2860

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.

Prognostic factors in brain metastases: can we determine patients who do not benefit from whole-brain radiotherapy?

Concomitant treatment of brain metastasis with whole brain radiotherapy [WBRT] and temozolomide [TMZ] is active and improves quality of life

Phase I/II trial of simultaneous whole-brain irradiation and dose-escalating topotecan for brain metastases.

Adjuvant treatment of brain metastases.

Improved survival, quality of life, and quality-adjusted survival in breast cancer patients treated with efaproxiral (Efaproxyn) plus whole-brain radiation therapy for brain metastases.

Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: results of Radiation Therapy Oncology Group trial BR-0018.

Radiotherapeutic management of brain metastases: a systematic review and meta-analysis.

A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104.

Quality-of-life assessment in the symptom management trials of the National Cancer Institute-supported Community Clinical Oncology Program.

P304

25-45

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3747/CO.V15I5.196

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19008990

http://www.w3.org/2001/XMLSchema#string

P932

2582512

http://www.w3.org/2001/XMLSchema#string